. . .: "fremanezumab for the preventive treatment of chronic migraine." . march 2018 (23) . .-related side effects. its manufacturer, eli lilly, plans to submit a new drug application to the fda in the second half of 2018. http://lm360.us/Gage-daughter-of-Cheyne-from-Konistres?Monardgra=184 scottish widows has its eyes on the master trust prize .